Replies to post #68537 on NorthWest Biotherapeutics Inc (NWBO)

[AVII77]

Are you kidding me? Of course there is evidence. You provided it.

Using the trial you cited as a proxy we would expect 22 psPD patients in the Info Arm. Do you contest that very basic observation.

Their defense would be: Well we said these patients "had actual or apparent early progression", we can't help it if greedy naive investors ignore the "or apparent" part of the title.

The morally despicable part of it though is when those naive greedy investors parrot the claims of NWBO management on patient message boards and leave out the "or apparent" part.

Equally despicable is when NWBO management present updates to this data to physicians, researchers and perhaps even patients and say it was "presented at ASCO" implying it had enough merit to actually be chosen for presentation at ASCO.
the scientific equivalent of stolen valor

Go ahead. Defend that! Provide the link to the ASCO abstract. If you can't I'm sure you'll agree that it should be reported to the relevant authorities. I trust you will handle that.